Randomized, Open-label Trial of Inhibitory Effect of Evogliptin on Progression of CAVD

NCT04521452 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

218

Enrollment

OTHER

Sponsor class

Conditions

CAVD

Interventions

DRUG: Evogliptin

Sponsor

Asan Medical Center

Collaborators

[object Object]